Compound class:
Synthetic organic
Comment: Compound 10 is a long-acting prodrug of the TGFβR inhibitor BMS-986260 [1]. It contains a matriptase peptide substrate domain, that is cleaved by the protease selectively in the tumour microenvironment. Compound 10 is sufficiently soluble to allow parenteral administration.
We generated the chemical structure shown here from the SMILES provided in the disclosure [1]. This prodrug approach is proposed to limit exposure of non-tumour tissue to the active parent molecule. |
|
Classification ![]() |
|
Compound class | Synthetic organic |
Is prodrug? | Yes |
Active form | BMS-986260 |
Database Links ![]() |
|
GtoPdb PubChem SID | 458923837 |
PubChem CID | 162366974 |
Search Google for chemical match using the InChIKey | RRGOOOPOTXFKKZ-UNVBUFFDSA-N |
Search Google for chemicals with the same backbone | RRGOOOPOTXFKKZ |
UniChem Compound Search for chemical match using the InChIKey | RRGOOOPOTXFKKZ-UNVBUFFDSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | RRGOOOPOTXFKKZ-UNVBUFFDSA-N |